In recognition of Ovarian Cancer Awareness Month, we highlight the story of Kate Kaplan, whose battle with mucinous adenocarcinoma—an extremely rare and aggressive form of ovarian cancer—underscores the urgent need for more research and awareness. This devastating disease may not respond to chemotherapy and often carries a poor prognosis if not caught early. In Kate’s memory, we encourage you to support ongoing research efforts. Let’s work together to raise awareness and fight for a future where no one has to endure this loss. Please consider donating to the University of Miami Health System’s campaign in Kate’s honor. Your support can make a difference. #AspiraWomensHealth #OvarianCancerAwareness #OvarianCancerResearch #MucinousAdenocarcinoma #RareCancer#CancerAwareness #WomensHealth #GynecologicalCancer #OvarianCancerMonth #TealTalk #KnowTheSymptoms#CancerFundraiser #ReproductiveHealth #SupportResearch #InMemory #Donate #KateKaplan #UniversityofMiami#UofMiami #PatientAdvocacy #PatientAdvocate

What if we could predict ovarian cancer risk early enough to change patient management? In this Cleveland Clinic podcast, Dr. Kevin Elias discusses the MiDe and ORBIT studies, including how the research demonstrates the potential clinical utility of testing to help providers make more informed patient-management decisions. Listen now: my.clevelandclinic.org/podca… #OvarianCancer #WomensHealth #ClinicalUtility #PrecisionMedicine #AspiraWomensHealth

Did you know? Approximately 1 in 9 surgeries performed to remove an adnexal mass reveal a malignancy, underscoring the importance of accurate risk assessment before surgery. Improving pre-surgical decision-making has the potential to help patients receive the most appropriate care. $AWHL #WomensHealth #Oncology #PrecisionMedicine

Earlier risk assessment can support more informed decisions. According to a peer-reviewed study, Ova1 accurately detected 59% of ovarian cancer risks missed by CA-125 alone. Learn more: aspirawh.com/ova1plus/ $AWHL #PrecisionMedicine #OvarianCancer #OvarianCancerAwareness #CancerResearch

Be the first to know what's happening at Aspira Women's Health. Receive company news, investor updates and key announcements directly to your inbox. Subscribe today: ow.ly/1gzK50ZysfQ $AWHL #WomensHealth #Oncology #PrecisionMedicine

Innovation meets women's health. Aspira Women's Health is focused on developing and commercializing AI-powered diagnostic solutions to help improve gynecologic care. Learn more: aspirawh.com/our-story/ #AWHL #WomensHealth #Oncology #PrecisionMedicine

Want to learn more about Aspira Women’s Health? Discover how we are advancing women’s health through AI-powered diagnostics and innovative testing solutions designed to improve gynecologic care. Visit our story: ow.ly/IfVA50ZituO $AWHL #WomensHealth #GynecologicHealth

When it comes to ovarian cancer risk assessment, confidence matters. OvaWatch has demonstrated a negative predictive value (NPV) of greater than 99%, helping provide additional insight when evaluating ovarian masses. $AWHL #WomensHealth #OvarianCancerAwareness

#InCaseYouMissedIt Aspira Women’s Health expanded its collaboration with Cleveland Clinic to advance AI-powered diagnostics and innovation in women’s health. Read more here: ow.ly/g7Rc50Zitsh $AWHL #WomensHealth

#WhoWeAre At Aspira Women’s Health, we are harnessing the power of AI and data-driven insights to advance women's health, delivering innovative testing solutions designed to bring greater clarity to gynecologic care. #AWHL #OvarianCancer #GynecologicHealth #WomensHealth

As America celebrates 250 years of progress and possibility, we’re reminded that advancing women’s health is an important part of building a stronger future. Wishing everyone a safe and happy Fourth of July from all of us at Aspira Women’s Health. #IndependenceDay

Advancing Innovation in Women's Health Care $AWHL is committed to improving gynecologic care through diagnostic solutions that empower physicians and support more confident, informed care decisions for women. #OvarianCancerAwareness #Endometriosis #GynecologicHealth #WomensHealth

Ovarian cancer causes more deaths than any other gynecologic cancer, often because it is diagnosed at later stages. Aspira Women’s Health is focused on advancing tools designed to support earlier detection and better outcomes. $AWHL #OvarianCancerAwareness #Endometriosis #GynecologicHealth #WomensHealth

#DidYouKnow According to a peer-reviewed study, Ova1 accurately detected 59% of ovarian cancer risks that were missed by CA-125 alone. $AWHL #OvarianCancerAwareness #Endometriosis #GynecologicHealth #WomensHealth

At $AWHL, our mission is to transform gynecologic disease detection through AI-powered diagnostics that support earlier and more informed clinical decision-making. #OvarianCancerAwareness #Endometriosis #GynecologicHealth #WomensHealth

Stay connected with Aspira Women’s Health. Sign up for email alerts to receive the latest company updates, women’s health news and investor information directly to your inbox. Sign up here: ir.aspirawh.com/email-alerts $AWHL #OvarianCancerAwareness #Endometriosis #GynecologicHealth #WomensHealth

On National Cancer Survivors Day, we recognize the fighters, survivors, families and caregivers impacted by cancer. Your strength continues to inspire hope and drive the importance of advancing better care for patients everywhere. #AWHL #NationalCancerSurvivorsDay #WomensHealth

Today, $AWHL joins in recognizing National Cancer Survivors Month and celebrating the resilience of survivors around the world. We celebrate the journeys, strength and hope that continue to inspire progress in healthcare and research. #OvarianCancerAwareness #CancerSurvivorMonth #GynecologicHealth #WomensHealth

Aspira Women's Health and @ClevelandClinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health bit.ly/3RywXqK $AWHL #Collaboration #BiotechDeal #AIPowered #Diagnostics #WomensHealth #StrategicCollaboration #OvarianCancer #Endometriosis #GynecologicHealth

Aspira Women’s Health CEO, Mike Buhle, discusses the significance of the Company’s collaboration with the Cleveland Clinic and how the partnership supports Aspira’s long-term vision to advance innovation in women’s health diagnostics. bit.ly/3RywXqK $AWHL #Collaboration #BiotechDeal #AIPowered #Diagnostics #WomensHealth #StrategicCollaboration #OvarianCancer #Endometriosis #GynecologicHealth